<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638596</url>
  </required_header>
  <id_info>
    <org_study_id>HSC20160425H</org_study_id>
    <secondary_id>5R01AA014988</secondary_id>
    <nct_id>NCT03638596</nct_id>
  </id_info>
  <brief_title>Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants</brief_title>
  <official_title>Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center at San Antonio</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study will evaluate the efficacy of contingency management (i.e., reinforcement
      for avoiding heavy drinking) among adults arrested for drunk driving and who are at risk for
      ongoing heavy drinking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Individuals who have a drunk driving arrest and are at risk for ongoing heavy drinking will
      be recruited to test the efficacy of contingency management for reducing alcohol use and
      identifying mechanisms of change. We will recruit those arrested for drunk driving offenses,
      â‰¥ 21 years of age, who at risk for ongoing heavy alcohol use and randomize them to one of two
      groups: control or a contingency management. Participants experience 8 weekly assessments of
      current alcohol use and other variables associated with changes in alcohol use.
      Post-intervention, participants will return to the laboratory once per month at 3, 6, 9, and
      12 months post-study entry for follow-up procedures to determine the mechanisms of drinking
      behavior change.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>random assignment to treatment and control arms</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent heavy drinking days</measure>
    <time_frame>8-weeks</time_frame>
    <description>Percent of days with estimated breath alcohol concentration .08% or higher or self-reported drinks &gt; 5 for men and &gt; 4 for women</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent drinking days</measure>
    <time_frame>8-weeks</time_frame>
    <description>Percent of days with any positive transdermal alcohol concentration &gt;.02 or any self-reported drinks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up percent heavy drinking days</measure>
    <time_frame>12-months</time_frame>
    <description>Self-reported drinks &gt; 5 for men and &gt; 4 for women</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up percent drinking days</measure>
    <time_frame>12-months</time_frame>
    <description>Any self-reported drinks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Drunk Driving</condition>
  <arm_group>
    <arm_group_label>Contingency Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Incentive delivery contingent upon maintaining transdermal alcohol concentration below cut-off</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Incentive delivery not contingent on transdermal alcohol concentration</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <description>Incentive provided for changing alcohol drinking patterns based on ankle monitor</description>
    <arm_group_label>Contingency Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Incentive provided is not contingent on alcohol drinking patterns based on ankle monitor</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  arrested for drunk driving offense

        Exclusion Criteria:

          -  significant alcohol withdrawal symptoms

          -  medical condition that would contraindicate participation (e.g., pregnancy, scheduled
             surgery)

          -  inability to comprehend the informed consent process or study instructions

          -  presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium

          -  incarceration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald M Dougherty, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center San Antonio</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Donald Dougherty, PhD</last_name>
    <phone>210-567-2726</phone>
    <email>doughertyd@uthscsa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tara Karns-Wright, PhD</last_name>
    <phone>210-567-4751</phone>
    <email>wrightt3@uthscsa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Texas Health Science Center San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald Dougherty, PhD</last_name>
      <phone>210-567-2728</phone>
      <email>doughertyd@uthscsa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tara Karns-Wright, PhD</last_name>
      <phone>210-567-2720</phone>
      <email>wrightt3@uthscsa.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 16, 2018</study_first_submitted>
  <study_first_submitted_qc>August 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>October 17, 2019</last_update_submitted>
  <last_update_submitted_qc>October 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alcohol Impaired Driving</keyword>
  <keyword>Driving While Intoxicated</keyword>
  <keyword>Driving Under the Influence</keyword>
  <keyword>Driving While Impaired</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

